D藥業(yè)集團的滿藥生產(chǎn)現(xiàn)狀及對策研究
[Abstract]:Objective: this subject will investigate and study the current situation of drug production in D pharmaceutical group, find out the problems existing in the drug production in D pharmaceutical group, and put forward some effective suggestions and countermeasures to speed up the development of Manchu medicine in D pharmaceutical group, and to find out the problems existing in the drug production in D pharmaceutical group. Promote the development of Manchu medicine industry, and further improve people's health literacy, effectively promote people's well-being. Methods: firstly, the related theories, laws and regulations were summarized, secondly, books, periodicals, newspapers and Internet about Manchurian drugs were reviewed by literature research method, which was the basis of studying the present situation of Manchurian medicine production in D Pharmaceutical Group. Through the method of interview with relevant people and the combination of theoretical knowledge and practical investigation, this paper reflects the present situation of the development of Manchu drug production in D Pharmaceutical Group. Finally, the research results are analyzed. Results: the investigation results showed that under the environment of the rapid development of the national drug industry in recent years, the full drug industry was also developing rapidly. Liaoning Province has abundant resources of Manchu medicinal materials. Manchu is a unique national medicine. However, there are still some problems in R & D, production and marketing in D Pharmaceutical Group. Conclusion: in order to promote the healthy development of the Manchurian medicine industry, the study of books, periodicals, newspapers and the Internet, as well as interviews with relevant people, The following targeted countermeasures and suggestions are put forward: in R & D, D Pharmaceutical Group should be market-oriented, co-produce, study, research and research twice on large varieties. D Pharmaceutical Group should standardize production in terms of production. Innovation in production technology and implementation of total quality management. D Pharmaceutical Group in the marketing aspect to improve customer satisfaction and build a full brand of drugs. The innovation of this study is that there is little research on Manchu medicine industry at present, and this paper is also the first example of the study on the production status of Manchu medicine enterprises. In this paper, by means of literature research and interviews with relevant people, the present situation of drug production in D pharmaceutical group is investigated. After discovering the problems existing in the drug production in D pharmaceutical group, the existing problems are solved.
【學位授予單位】:遼寧中醫(yī)藥大學
【學位級別】:碩士
【學位授予年份】:2017
【分類號】:F426.72
【參考文獻】
相關期刊論文 前6條
1 李赫;;首屆中國滿族醫(yī)藥及健康產(chǎn)品博覽會暨2016第四屆滿族醫(yī)藥國際論壇在遼寧丹東舉行[J];滿族研究;2016年03期
2 劉志學;;宋玉榮:鐘情“滿族醫(yī)藥”三十年[J];中國醫(yī)藥導報;2012年19期
3 詹洪春;;民族醫(yī)藥再推“滿族醫(yī)藥”新品牌[J];中國當代醫(yī)藥;2010年24期
4 馬萬學;劉玉忠;;滿族傳統(tǒng)醫(yī)藥的傳承與應用[J];滿族研究;2009年02期
5 ;數(shù)據(jù)表明:我國民族藥材品種已達8000多種[J];中藥研究與信息;2005年12期
6 梁廷信;滿族常用藥簡介[J];中國民族醫(yī)藥雜志;2000年01期
相關會議論文 前1條
1 林瑞超;;中國民族藥的現(xiàn)狀與發(fā)展[A];2013年中國藥學大會暨第十三屆中國藥師周報告集[C];2013年
相關重要報紙文章 前6條
1 張旭;;丹東:打造中國“滿藥”之都[N];中國中醫(yī)藥報;2014年
2 羅朝淑;;遼寧丹東著力打造中國“滿藥之都”[N];科技日報;2014年
3 王抒婧;;白山黑水間的滿族醫(yī)藥文化[N];丹東日報;2013年
4 李瑤;;后起民族藥期待理論上位[N];醫(yī)藥經(jīng)濟報;2012年
5 陶晉;;2012滿族醫(yī)藥國際論壇在丹舉行[N];丹東日報;2012年
6 叢曉明;;振興滿族醫(yī)藥[N];丹東日報;2012年
相關博士學位論文 前1條
1 范春芳;少數(shù)民族藥產(chǎn)業(yè)科學發(fā)展的路徑研究[D];中央民族大學;2010年
相關碩士學位論文 前2條
1 趙琪;內(nèi)蒙古大唐藥業(yè)有限公司中蒙藥戰(zhàn)略研究[D];內(nèi)蒙古大學;2013年
2 方曦;貴州省中小制藥企業(yè)發(fā)展戰(zhàn)略研究[D];上海交通大學;2009年
,本文編號:2467262
本文鏈接:http://sikaile.net/gongshangguanlilunwen/2467262.html